Macdanib 150mg Capsule
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Nintedanib (150mg)
Overview Macdanib 150mg Capsule
Nuvigen 150mg capsules treat idiopathic pulmonary fibrosis and non-small cell lung carcinoma. Its mechanism targets specific cellular pathways crucial to disease progression, inhibiting cancer cell proliferation. Consume Nuvigen 150mg capsules with food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician, dependent on your condition and subject to adjustment. Adhere strictly to prescribed instructions; improper usage or overdose can cause severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under your doctor's guidance. Diarrhea is a frequent side effect; maintain adequate hydration and report persistent symptoms. Other common side effects include nausea, stomach pain, vomiting, altered liver function test results, decreased appetite, headache, weight loss, and hypertension. Liver function monitoring via blood tests may be required. Before initiating treatment, inform your physician of any bleeding disorders, liver or kidney issues, or concurrent use of antimicrobial medications. This medication can interact with other drugs; disclose all medications to your healthcare provider. Nuvigen 150mg capsules are contraindicated during pregnancy and breastfeeding. Reliable contraception is vital for both partners throughout treatment to prevent conception.
Uses of Macdanib 150mg Capsule
Managing idiopathic pulmonary fibrosis and non-small cell lung cancer.
Major Benefits of Macdanib 150mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume the Macdanib 150mg Capsule with a meal.
Common Side effects of Macdanib 150mg Capsule:
- Diarrhea
- Nausea
- Abdominal pain
- Vomiting
- Abnormal liver function tests
- Loss of appetite
- Headache
- Weight loss
- High blood pressure
How to use Macdanib 150mg Capsule:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Consume the Macdanib 150mg Capsule with a meal.
How Macdanib 150mg Capsule works:
Oncasin capsules (150mg) are an anticancer drug. Their mechanism involves inhibiting aberrant proteins that stimulate cancerous cell proliferation. Additionally, they suppress fibrotic pathways, thereby reducing tissue thickening and scarring. This dual action contributes to cancer growth inhibition.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Macdanib 150mg Capsules may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Macdanib 150mg Capsules is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Macdanib 150mg capsules while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 150mg Macdanib capsule might lead to adverse reactions that impair your driving ability. Nausea is a possible side effect, potentially impacting your capacity to drive safely.
KidneyCAUTION
Patients with severe kidney impairment should use Macdanib 150mg capsules cautiously, potentially requiring dosage modification. Consult a physician; data on Macdanib 150mg capsule use in such patients is scarce.
LiverCAUTION
Patients with liver impairment should use Macdanib 150mg capsules cautiously, potentially requiring dose modification. Consult a physician before use. Macdanib 150mg capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Macdanib 150mg Capsule :
Omit any missed Macdanib 150mg Capsule and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Macdanib 150mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Indole-2-carboxylic acids |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Tyrosine kinase inhibitor drugs |
3,018 People bought this recently